Literature DB >> 16492425

Nontraditional cardiovascular risk factors in pediatric metabolic syndrome.

Ravi Retnakaran1, Bernard Zinman, Philip W Connelly, Stewart B Harris, Anthony J G Hanley.   

Abstract

OBJECTIVE: To study the relationships between nontraditional cardiovascular (CV) risk factors and components of the metabolic syndrome in Native Canadian children, a population at risk of future CV disease. STUDY
DESIGN: CV risk factors were evaluated in a population-based study of a Canadian Oji-Cree community, involving 236 children aged 10 to 19 years.
RESULTS: Using an age- and sex-specific case definition, 18.6% of the children met criteria for pediatric metabolic syndrome. As the number of metabolic syndrome component criteria increased, C-reactive protein, leptin, and ratio of apolipoprotein B to apolipoprotein A1 levels rose (all P < .0001) and adiponectin concentration decreased (P = .0006). Principal factor analysis using both traditional and nontraditional CV risk factors revealed 5 underlying core traits, defined as follows: adiposity, lipids/adiponectin, inflammation, blood pressure, and glucose.
CONCLUSIONS: Nontraditional CV risk factors accompany the accrual of traditional risk factors early in the progression to pediatric metabolic syndrome. Furthermore, inclusion of these factors in factor analysis suggests that 5 core traits underlie the early development of an enhanced CV risk factor profile in Native children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492425     DOI: 10.1016/j.jpeds.2005.08.025

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Utility of ApoB/ApoA1 ratio for the prediction of cardiovascular risk in children with metabolic syndrome.

Authors:  S Savas Erdeve; E Simsek; Yildiz Dallar; Zeynep Biyikli
Journal:  Indian J Pediatr       Date:  2010-10-06       Impact factor: 1.967

Review 2.  Childhood obesity and adult morbidities.

Authors:  Frank M Biro; Michelle Wien
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

3.  Changes in metabolic syndrome of Korean children and adolescents in the period 1998 to 2001.

Authors:  S Lim; H C Jang; K S Park; H K Lee; H R Chung; H J Joung; S I Cho
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

4.  Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial.

Authors:  Ruth S Weinstock; Kimberly L Drews; Sonia Caprio; Natasha I Leibel; Siripoom Vudhipoom McKay; Philip S Zeitler
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

5.  Associations of dietary intake patterns identified using reduced rank regression with markers of arterial stiffness among youth with type 1 diabetes.

Authors:  A P Lamichhane; A D Liese; E M Urbina; J L Crandell; L M Jaacks; D Dabelea; M H Black; A T Merchant; E J Mayer-Davis
Journal:  Eur J Clin Nutr       Date:  2014-05-28       Impact factor: 4.016

6.  Racial differences in myocardial deformation in obese children: Significance of inflammatory state.

Authors:  T J Popp; M H Henshaw; J Carter; T N Thomas; S M Chowdhury
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-02-02       Impact factor: 4.222

Review 7.  Intima-media thickness measurements in children with cardiovascular risk factors.

Authors:  Mieczysław Litwin; Anna Niemirska
Journal:  Pediatr Nephrol       Date:  2008-09-11       Impact factor: 3.714

8.  Factor analysis of metabolic syndrome components in severely obese girls and boys.

Authors:  C L Lafortuna; F Adorni; F Agosti; A De Col; R Zennaro; D Caranti; A Sartorio
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

Review 9.  Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology.

Authors:  J S Yudkin
Journal:  Diabetologia       Date:  2007-06-26       Impact factor: 10.122

10.  Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth.

Authors:  Ravi Retnakaran; Philip W Connelly; Stewart B Harris; Bernard Zinman; Anthony J G Hanley
Journal:  Pediatr Nephrol       Date:  2007-03-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.